|
OMIM |
Link |
Information gain |
01 |
|
PFIC1
|
[NCBI]
|
0.00151251
|
|
|
ABCB11
|
[NCBI]
|
0.00138213
|
|
|
cholestasis-lymphedema syndrome
|
[NCBI]
|
0.00116675
|
|
|
ALGS1
|
[NCBI]
|
0.000996912
|
|
|
BRIC1
|
[NCBI]
|
0.000931816
|
|
|
ICP
|
[NCBI]
|
0.000752347
|
|
|
PFIC2
|
[NCBI]
|
0.000428757
|
|
|
ATP8B1
|
[NCBI]
|
0.000385114
|
|
|
ABCB4
|
[NCBI]
|
0.00037861
|
|
|
PFIC3
|
[NCBI]
|
0.000351597
|
|
|
citrullinemia, type ii, neonatal-onset
|
[NCBI]
|
0.000258801
|
|
|
cholestasis, benign recurrent intrahepatic 2
|
[NCBI]
|
0.000234146
|
|
|
bile acid synthesis defect, congenital, 1
|
[NCBI]
|
0.000179631
|
|
|
SLC25A13
|
[NCBI]
|
0.000172406
|
|
|
NAIC
|
[NCBI]
|
0.000172283
|
|
|
CTLN2
|
[NCBI]
|
0.000149704
|
|
|
cholestasis with gallstone, ataxia, and visual disturbance
|
[NCBI]
|
0.000116948
|
|
|
NR1H4
|
[NCBI]
|
0.000113621
|
|
|
SLE
|
[NCBI]
|
8.53718e-05
|
|
|
CIRH1A
|
[NCBI]
|
7.75317e-05
|
|
|
mevalonic aciduria
|
[NCBI]
|
7.31844e-05
|
|
|
bile acid synthesis defect, congenital, 2
|
[NCBI]
|
6.81699e-05
|
|
|
arthrogryposis, renal dysfunction, and cholestasis
|
[NCBI]
|
6.81699e-05
|
|
|
amyloidosis, familial visceral
|
[NCBI]
|
6.61501e-05
|
|
|
NR1I2
|
[NCBI]
|
6.60941e-05
|
|
|
ASS
|
[NCBI]
|
6.52221e-05
|
|
|
SLCO1B1
|
[NCBI]
|
6.3755e-05
|
|
|
hemochromatosis, neonatal
|
[NCBI]
|
5.87043e-05
|
|
|
HSD3B7
|
[NCBI]
|
5.85576e-05
|
|
|
CARM1
|
[NCBI]
|
5.85576e-05
|
|
|
citrullinemia, classic
|
[NCBI]
|
4.6219e-05
|
|
|
LCAT
|
[NCBI]
|
4.17611e-05
|
|
|
LIPC
|
[NCBI]
|
2.82446e-05
|
|
|
CF
|
[NCBI]
|
1.7194e-05
|
|
|
PI
|
[NCBI]
|
1.3178e-05
|
|
|
AFP
|
[NCBI]
|
4.29874e-06
|
|
|
VEGF
|
[NCBI]
|
2.6019e-06
|
|
|
EGF
|
[NCBI]
|
2.01232e-06
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
1.97698e-06
|
|
|
PTH
|
[NCBI]
|
1.29623e-06
|
|
|
HGF
|
[NCBI]
|
9.19204e-07
|
|
|
CEACAM5
|
[NCBI]
|
2.98802e-07
|
|
|
APOE
|
[NCBI]
|
2.16271e-07
|
|
|
PCNA
|
[NCBI]
|
3.88583e-08
|
|
|
EPO
|
[NCBI]
|
2.27914e-08
|
|
|
MPO
|
[NCBI]
|
2.24989e-08
|
|